The UK’s Joint Committee on Vaccination and Immunisation (JCVI) issued advice today that young people (12 to 15) at increased risk for serious COVID-19 disease should be offered the Pfizer-BioNTech (Comirnaty) vaccine.
This new JCVI advice includes those with severe neuro disabilities, Down’s syndrome, immunosuppression, and multiple or severe learning disabilities.
Read More
